TIDMCLL

Cello Group plc

13 March 2012

13 March 2012

Cello Group plc

Launch of CSR programme

Cello Group plc (AIM:CLL, 'Cello', or 'the Group'), the insight and strategic marketing group, has today launched its new Corporate Social Responsibility programme 'Talking Taboos'.

Talking Taboos is a campaigning brand that aims to directly tackle health and social issues using Cello's experience and resources in the healthcare space. It will focus on areas where embarrassment, fear or ignorance prevents sufferers from seeking help.

For 2012, Talking Taboos will be addressing teen mental health, specifically self-harm, through an extensive research project with the teen charity YoungMinds. The research will examine the context in which teenagers find themselves when actively self-harming, and will attempt to inform parents, teachers, peers and health professionals how best to identify and support at-risk and self-harming teens.

Each Cello Group company will utilise its expertise in methodology or market sector to contribute to a 'whole community' view that will help carers and sufferers by providing context, exploding myths and challenging prevailing attitudes to self-harm. The programme is being led by Vincent Nolan, Group Chairman of Cello Research and Consulting, and the Group is planning to expand this initiative in the future to assist organisations which address a range of health related issues.

Mark Scott, Cello Group CEO, said:

"Talking Taboos is a great opportunity for us to support a worthwhile cause in the best way we know how - through our market leading research and our wealth of experience in working with health issues.

"It is also an ideal way for our companies to demonstrate their abilities and talents and work across the group to deliver a comprehensive project that should help change the way that self-harm is perceived and handled."

Enquiries:

 
 Cello Group plc (www.cellogroup.com) 
 Mark Scott, Chief Executive                       020 7812 8460 
 Mark Bentley, Group Finance Director 
 Vincent Nolan, Group Chairman - Cello Research 
  and Consulting                                   020 7655 9900 
 Cenkos 
 Bobbie Hilliam                                    020 7397 8900 
 
 College Hill 
 Kay Larsen/Rozi Morris                            020 7457 2020 
 

Notes to Editors (www.cellogroup.com)

Cello is an insight and strategic marketing group.

The Group's strategy is to create value for shareholders by building an international research and consulting business able to advise blue chip clients globally, along with a marketing business capable of delivering world class solutions.

Cello has annualised revenues in excess of GBP130m, annualised gross profit in excess of GBP65m and employs over 700 professional staff.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAGGUUWWUPPGMP

Cello Health (LSE:CLL)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Cello Health Charts.
Cello Health (LSE:CLL)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Cello Health Charts.